Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo

Apoptosis

Volumn 13, Issue 5, 2008, Pages 641-648

  Ruan, Guo Rui ^a   Zhao, Hong Shan ^b   Chang, Yan ^a   Li, Jin Lan ^a   Qin, Ya Zhen ^a   Liu, Yan Rong ^a   Chen, Shan Shan ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Adenoviral vector; Gene therapy; Idarubicin; Leukemia; Nude mice; PDCD5

Indexed keywords

ADENOVIRUS VECTOR; FLUORESCEIN ISOTHIOCYANATE; IDARUBICIN; LIPOCORTIN 5; PROGRAMMED CELL DEATH PROTEIN 5; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL STRAIN K 562; CHEMOSENSITIZATION; CHRONIC MYELOID LEUKEMIA; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIVITY; EX VIVO STUDY; FEMALE; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LOW DRUG DOSE; MONOTHERAPY; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; IDARUBICIN; K562 CELLS; MICE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 42149115621     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-008-0206-9     Document Type: Article

References (33)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70
2. Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411(6835):342-348
3. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17(25):3247-3259
4. Miyake H, Hara I, Hara S, Arakawa S, Kamidono S (2000) Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model. Urology 56(2):332-336
5. Tuve S, Racek T, Niemetz A, Schultz J, Soengas MS, Pützer BM (2006) Adenovirus-mediated TA-p73beta gene transfer increases chemosensitivity of human malignant melanomas. Apoptosis 11(2):235-243
6. Okumura K, Nakase M, Nakamura S, Kamei T, Inui M, Tagawa T (2007) Bax gene therapy for human osteosarcoma using cationic liposomes in vivo. Oncol Rep 17(4):769-773
7. Liu H, Wang Y, Zhang Y, Song Q, Di C, Chen G et al (1999) TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254(1):203-210
8. Zhang YM, Xu XZ, Liu HT, Song QS, Ma DL (2000) The apoptosis-accelerating effect of human recombinant TFAR19 protein on leukemia HL-60 cells. J Chin Immunol 16:8-11
9. Ruan GR, Chen SS, Chang Y, Fu JY, Wan H, Qin YZ et al (2002) Abnormality expression of a novel apoptosis-promoting molecule TFAR19 (PDCD5) in the bone marrow cells from adult chronic myeloid leukemia. J Peking Univ (Health Sci) 34:676-679
10. Ruan GR, Qin YZ, Chen SS, Li JL, Ma X, Chang Y et al (2006) Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 30(9):1159-1165
11. Wang Y, Li X, Wang L, Ding P, Zhang Y, Han W et al (2004) An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 117(Pt 8):1525-1532
12. Chen Y, Douglass T, Jeffes EW, Xu Q, Williams CC, Arpajirakul N et al (2002) Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas. Blood 100(4):1373-1380
13. Dal Canto MC, Gurney ME (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145(6):1271-1279
14. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q et al (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98(26):15089-15094
15. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R et al (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344(8):539-548
16. Liu ZH, Zhang D, Li KM, Liao QP (2004) Expression of PDCD5 in tissues of normal cervix, CIN I-III and cervical cancer. J Peking Univ (Health Sci) 36(4):407-410
17. Du Y, Hong T (2003) A preliminary study on the relationship between TF-1 cell apoptosis-related gene 19 and thyroid tumor. Chin J Intern Med 42:492-494
18. Yang YH, Zhao M, Li WM, Lu YY, Chen YY, Kang B et al (2006) Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11(6):993-1001
19. Ruan GR, Chen SS, Chang Y, Li JL, Qin YZ, Li LD et al (2007) Adenovirus-mediated PDCD5 gene transfer sensitizes apoptosis of K562 cells induced by etoposide. J Exp Hematol 15:936-940
20. Creutzig U, Körholz D, Niemeyer CM, Kabisch H, Graf N, Reiter A et al (2000) Toxicity and effectiveness of high-dose idarubicin during AML induction therapy: results of a pilot study in children. Klin Padiatr 212(4):163-168
21. Rockwell SC, Kallman RF, Fajardo LF (1972) Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst 49(3):735-749
22. Milas L, Raju U, Liao Z, Ajani J (2005) Targeting molecular determinants of tumor chemo-radioresistance. Semin Oncol 32(6 Suppl 9):S78-S81
23. Kohn KW, Pommier Y, Kerrigan D, Markovits J, Covey JM (1987) Topoisomerase II as a target of anticancer drug action in mammalian cells. NCI Monogr (4):61-71
24. Isaacs RJ, Davies SL, Wells NJ, Harris AL (1995) Topoisomerases II alpha and beta as therapy targets in breast cancer. Anticancer Drugs 6(2):195-211
25. Dartsch DC, Gieseler F (2007) Repair of idarubicin-induced DNA damage: a cause of resistance? DNA Repair (Amst) 6(11):1618-1628
26. Berger JM, Gamblin SJ, Harrison SC, Wang JC (1996) Structure and mechanism of DNA topoisomerase II. Nature 379(6562):225-232
27. Cheon J, Ko SC, Gardner TA, Shirakawa T, Gotoh A, Kao C et al (1997) Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model. Cancer Gene Ther 4(6):359-365
28. Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L et al (2000) Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 18(3):609-622
29. Dong YB, Yang HL, Elliott MJ, McMasters KM (2002) Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. Cancer Res 62(6):1776-1783
30. Ma X, Ruan G, Wang Y, Li Q, Zhu P, Qin YZ et al (2005) Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5' regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res 11(24 Pt 1):8592-8599
31. Chen Y, Sun R, Han W, Zhang Y, Song Q, Di C et al (2001) Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509(2):191-196
32. Zou XJ, Peng JR, Zhong LJ, Lou YX, Liu D, Yang B et al (2006) Study on the interaction between PDCD5 and DNA Using MALDI-TOF-MS. J Chin Mass Spectrom Soc 27(suppl):179-180
33. Pai C, Wang A (2005) Structural study of DNA binding protein pdcd5 from sulfolobus solfataricus. Acta Cryst A 61:C224 (Abstr)